Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia.
about
Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and DiseasesPerspective Biological Markers for Autism Spectrum Disorders: Advantages of the Use of Receiver Operating Characteristic Curves in Evaluating Marker Sensitivity and SpecificityNutritional status of individuals with autism spectrum disorders: do we know enough?Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autismEtiology of autistic features: the persisting neurotoxic effects of propionic acidCysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autismDietary intake and plasma levels of choline and betaine in children with autism spectrum disorders.Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.Maternal folate status as a risk factor for autism spectrum disorders: a review of existing evidence.Lipid mediators in plasma of autism spectrum disorders.Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials.Nutrition and Autism: Intervention Compared with Identification.Microarray analysis of gene expression in the cyclooxygenase knockout mice - a connection to autism spectrum disorder.Comparative study on the independent and combined effects of omega-3 and vitamin B12 on phospholipids and phospholipase A2 as phospholipid hydrolyzing enzymes in PPA-treated rats as a model for autistic traits
P2860
Q26749210-A9B3445D-51D7-463E-B715-FC3CE762B3A7Q26773383-88B6263A-4653-4779-BE47-39432B1BBFECQ26801276-5B2ED366-9014-4D20-9C59-EE0458BB1FC5Q33916678-7322BF6E-54DC-45D2-847A-4EE72D3078AFQ34252062-C666607E-1EF9-4A5D-92FE-5F8F96412BC4Q36181687-C3FB342E-71BD-455E-B2D8-764BDFE73953Q37182335-AB18E9F0-CCD2-42FA-B993-164DFA6CE44FQ37422634-A33C71C6-B4CE-493C-8B4F-F00C964EE579Q37673257-CC5FE54B-229F-460D-8F28-6E8F1BA7A921Q38560962-4067CE00-C8AE-40F6-BA64-C020E9C9ECFBQ41918402-88A0B271-7409-4586-9727-3490C456FB4FQ42373848-C6CF5423-112B-4FC1-A6B0-9F2A4E498297Q42679600-DC01718B-2E0E-4AC7-9B9F-68AFD0F05EE9Q47378227-B55EC322-92A1-4BEB-AED4-2CD924EA4480Q58782068-6D179BEF-4972-4DD1-A88B-6CDFDCB6B788
P2860
Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@ast
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@en
type
label
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@ast
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@en
prefLabel
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@ast
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@en
P2093
P2860
P356
P1476
Impaired plasma phospholipids ...... ic patients from Saudi Arabia.
@en
P2093
Abir G Ben Bacha
Afaf K El-Ansary
Layla Y Al-Ayahdi
P2860
P2888
P356
10.1186/1476-511X-10-63
P577
2011-04-22T00:00:00Z